openPR Logo
Press release

Now Available Optic Nerve Disorders Drugs Market Forecast And Growth 2018 to 2026(Based on drug class, the global optic nerve disorders drugs market is segmented into: Steroids Nerve Tonics and Multivitamin Analgesics Anti-infective Hyperosmotic Agents Pa

05-28-2019 01:27 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Now Available Optic Nerve Disorders Drugs Market Forecast

Optic Nerve Disorders Drugs Market – Overview

Optic nerve disorder, commonly known as optic neuropathy, is a medical condition indicating degeneration of the optic nerve. While mostly optic nerve disorders are hereditary, few of them are also acquired over the time. Some of probable etiologies (set of causes) leading to optic nerve disorders can include nutritional, ischemic, and toxic types. Patients suffering from optic nerve disorders show marked preferences for optic nerve disorders drugs over surgeries for treating optic neuropathies, as they are highly cost-effective and minimally risky.

Use of steroid-based optic nerve disorders drugs has been in practice, on account of their efficacy in easing the symptoms of optic nerve disorders. With the inflow of multiple drugs, patients are developing higher confidence on these optic nerve disorders drugs’ types and moving away from surgical interventions.

Optic Nerve Disorders Drugs Market - Novel Developments

Some of the key market players operating in the optic nerve disorders drugs market include Novartis AG, Santhera Pharmaceuticals, Allergan plc., Stealth BioTherapeutics Inc., Quark, Takeda Pharmaceutical Company, Merck & Co., and others.

In 2019, Santhera Pharmaceuticals- a leading player in the optic nerve disorders drugs market- made an official announcement regarding its successful completion of patient enrollments in the on-going ‘Phase 1V’ study (LEROS) using Raxone® (idebenone) for treatment of hereditary optic neuropathies, otherwise known as optic nerve disorders. This 24- month long study was conducted across 31 study centers in the USA and Europe and the results are expected to be out by 2021.
In 2016, Quark Pharmaceuticals Inc. - a key player in the optic nerve disorders drugs market- partnered with Biocon Ltd., a leading biopharmaceutical firm to start various clinical trials of a drug meant to treat eye disorders. The study will further determine, over a duration of more than 12 months, the levels of efficacy and safety of drug candidate ‘;QPI-1007’ on the patients suffering from acute non-arteritic ischemic optic neuropathy (NAION), a medical condition wherein low blood supply to the optic nerves results in permanent vision impairment.

Request Free Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=2689

Optic Nerve Disorders Drugs Market- Dynamics

Optic Nerve Disorders Drugs Market - Pervasiveness of Optic Nerve Disorders Propels Growth

Rising number of instances of optic nerve disorders are indicating unabated demand for optic nerve disorders drugs in the coming years, thereby driving the optic nerve disorders drugs market. According to data by the World Health Organization (WHO), approx. 1.3 billion people suffer due to some sort of vision impairment. Among all the other possible causes, glaucoma (a condition leading to damage of optic nerves) has been identified as a prominent cause.

Rising demand for non-invasive procedures in the optometric space is also creating favorable grounds for optic nerve disorders drugs market. Patients, post realization of the risks and cost involved in surgical procedures, show high inclination toward optic nerve disorders drugs over surgeries, which is a key pacesetter of optic nerve disorders drugs market growth in the future.

Optic Nerve Disorders Drugs Market - Manufacturers Focus on Expansion of Product Pipelines to Achieve High Profitability

Manufacturers in the optic nerve disorders drugs market are vying to offer compliant and safe products, wherein reliability is given utmost importance for boosting end-user confidence. In addition, companies in the optic nerve disorders drugs market are also focusing on expansion of their product pipelines and effective management of internal sales & marketing teams to achieve long-term profitability.

However, manufacturers are likely to incur sizeable operating losses as they make investments, continue with developments, and commercialize new products in the optic nerve disorders drug development market. Higher operating expenses in tandem with development activities are anticipated to create significant challenges for players in the optic nerve disorders drugs market. In a bid to retain their profitability, manufacturers are focusing on successful completion of impending products, obtaining authorizations for seamless marketing, and competitive pricing. These factors, in turn, will be instrumental to solidify their sustenance in the optic nerve disorders drugs market.

Optic Nerve Disorders Drugs Market: Segmentation

The optic nerve disorders drugs market is segmented on the basis of indication, drug class, end user and region.

Based on indication, the global optic nerve disorders drugs market is segmented into:

Ischemic Optic Neuropathies
Optic Neuritis and Perineuritis
Papilledema
Compressive Optic Neuropathies
Intrinsic Neoplasms
Hereditary Optic Neuropathies
Inflammatory Optic Neuropathies
Infectious Optic Neuropathies
Toxic and Nutritional Optic Neuropathies
Traumatic Optic Neuropathy
Glaucoma
Optic Disc Drusen
Anomalous Optic Neuropathy
Based on drug class, the global optic nerve disorders drugs market is segmented into:

Steroids
Nerve Tonics and Multivitamin
Analgesics
Anti-infective
Hyperosmotic Agents
Parasympathomimetics
Carbonic Anhydrase Inhibitors
Beta-blockers and Alpha-adrenergic Agonists

Other

Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=2689

Based on end user, the global optic nerve disorders drugs market is segmented into:

Hospitals
Clinics
Home Settings
Optic Nerve Disorders Drugs Market: Overview

Based on regions, the global optic nerve disorders drugs market is classified into North America, Latin America, Europe, CIS & Russia, Japan, Asia-Pacific excluding Japan (APEJ), and the Middle East & Africa (MEA). North America is expected to account for the largest share in the global optic nerve disorders drugs market owing to large incomes and excellent reimbursements. The excellent support of the US government programs such as Prescription assistance programs, Resources for macular degeneration and glaucoma, Medicare, Medicaid, Social Security and others is driving a large optic nerve disorders market.

China and India are expected to drive the lion’s share in the optic nerve disorders drugs market in the Asia-Pacific excluding Japan (APEJ) region. The inclusion of glaucoma in national health programs in developing countries is driving a large market for optic nerve disorders.

The European optic nerve disorders drugs market is expected to be led by Germany, France and the UK. The Middle Eastern and African optic nerve disorders drugs market is anticipated to be dominated by the Gulf nations of Saudi Arabia, UAE, Kuwait and Qatar. The poor per capita income of African countries is likely to restrict the growth of the optic nerve disorders drugs market in this region.

Optic Nerve Disorders Drugs Market: Key Players

Some of the major players in the global optic nerve disorders drugs market are SANTHERA PHARMACEUTICALS, Quark, Novartis AG, Allergan plc, Merck & Co., Stealth BioTherapeutics Inc., Takeda Pharmaceutical Company, and others.

This market study is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The study provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The study also maps the qualitative impact of various market factors on market segments and geographies.

The market study covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes:

North America
US
Canada
Latin America
Brazil
Mexico
Argentina
Chile
Peru
Rest of LATAM
Europe
EU – 4 (Germany, France, Italy, Spain)
UK
BENELUX (Belgium, Netherlands, Luxemburg)
NORDIC (Norway, Denmark, Iceland, Sweden)
Eastern Europe (Poland, Ukraine, Czech Rep., etc.)
Rest of Europe
CIS & Russia
Japan
APEJ
Greater China
India
Korea
ASEAN Countries
Rest of APEJ
Middle East & Africa
GCC Countries
Turkey
Iran
Israel
South Africa
Rest of MEA
Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.

Report Analysis@ https://www.factmr.com/report/2689/optic-nerve-disorders-drugs-market

About US
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Now Available Optic Nerve Disorders Drugs Market Forecast And Growth 2018 to 2026(Based on drug class, the global optic nerve disorders drugs market is segmented into: Steroids Nerve Tonics and Multivitamin Analgesics Anti-infective Hyperosmotic Agents Pa here

News-ID: 1756037 • Views:

More Releases from Fact.MR

Insights into the Medical Gloves Market to Exceed US$ 27 Billion by 2034
04-19-2024 | Health & Medicine
Fact.MR
Insights into the Medical Gloves Market to Exceed US$ 27 Billion by 2034
The global medical gloves market (医療用手袋市場) is projected to reach a valuation of over US$ 27,141.5 million by 2034, growing from an estimated worth of US$ 11,299 million in 2024, with a forecasted compound annual growth rate (CAGR) of 9.2% until 2034. The increasing emphasis on hygiene and infection control, particularly in healthcare environments, is driving demand for medical gloves. This demand is further fueled by stringent regulations governing healthcare standards.
Aerial Inspection Services Market is accelerate at a CAGR of 17.5% to top US$ 9.5 billion by 2033.
Aerial Inspection Services Market is accelerate at a CAGR of 17.5% to top US$ 9. …
The global Aerial Inspection Services is expected to reach a value of US$ 1.9 billion and is projected to grow at a compound annual growth rate (CAGR) of 17.5% over the next decade, reaching US$ 9.5 billion by 2033.Drone inspection services dominate this market, accounting for approximately 90.0% of the total aerial inspection services sector. Moreover, this segment represents a significant portion, around 25.0%, of the broader drone services market,
Bioink Market Expected to Reach US$ 1.03 Billion by 2034 with 18.8% CAGR
04-19-2024 | Health & Medicine
Fact.MR
Bioink Market Expected to Reach US$ 1.03 Billion by 2034 with 18.8% CAGR
In 2024, the global bioink market (バイオインク市場) is estimated at US$ 185.6 million. Forecasts project a remarkable Compound Annual Growth Rate (CAGR) of 18.8%, catapulting the demand for bioinks to reach a substantial market value of US$ 1.03 billion by 2034. Recent years have witnessed a consistent rise in the necessity for organ replacements and tissue regeneration. Innovations in these fields are anticipated to facilitate the transformation of damaged tissues into
Bonded Magnet Market is forecast to reach a valuation of US$ 10.9 Billion by 2032
Bonded Magnet Market is forecast to reach a valuation of US$ 10.9 Billion by 203 …
The Bonded Magnet Market is currently valued at around US$ 5.1 billion, and it is expected to experience substantial growth in the coming years. Projections suggest that the market will reach a valuation of US$ 10.9 billion by 2032, growing at an impressive compound annual growth rate (CAGR) of 7.8% from 2022 to 2032. Bonded magnets play a significant role in the global magnet market, accounting for approximately 14% of its

All 5 Releases


More Releases for Optic

Optic Nerve Disorders Drugs Market Projected to Discern Stable Expansion During …
The optic nerve consists of more than one million nerve fibers and its function is to carry visual messages to the brain. Optic nerve disorders cause damage to the nerve due to factors ranging from infection to trauma. Damage to an optic nerve can cause vision loss, reduction in visual acuity, loss or reduction in color vision, pupil response abnormality and others. Optic nerve disorders drugs are used for the
Global fiber optic connectivity market | fibre broadband, fiber internet, fiber …
In order to study the various trends and patterns prevailing in the concerned market, Market Research Reports Search Engine (MRRSE) has included a new report titled “Global Fiber Optic Connectivity Market” to its wide online database. This research assessment offers a clear insight about the influential factors that are expected to transform the global market in the near future. The fiber optic connectivity market report provides analysis for the period 2016
Global Presents Fiber-optic Filters Market Growth and Forecast 2018 to 2028(Segm …
Fiber-optic filters market: Market Overview Due to increasing reliance of organizations on IT (Information Technology), the demand for robust, agile and cost effective IT infrastructure is growing rapidly. The fabric-optic filter market is expanding rapidly as the telecom service providers in this modern era are moving towards fiber-based networking services. Increasing advancements in telecom industry is one of the major factors driving the growth of the fiber-optic filter market worldwide. Furthermore,
Fiber-optic couplers Market Segmentation By Type Y Fiber-optic Couplers, T Fiber …
Fiber-optic couplers market: Market Overview Due to increasing reliance of organizations on IT, the demand for robust, agile and cost effective IT infrastructure is growing rapidly and supporting the Fiber-optic couplers market. The fabric-optic couplers market is expanding rapidly as the telecom services providers in this modern era are moving towards fiber based networking services. Increasing advancements in the telecom industry are one of the major factors driving the growth of
Fiber-optic Filters Market Segmentation By Type Digital Fiber-optic Filters, Man …
Fiber-optic filters market: Market Overview Due to increasing reliance of organizations on IT (Information Technology), the demand for robust, agile and cost effective IT infrastructure is growing rapidly. The fabric-optic filter market is expanding rapidly as the telecom service providers in this modern era are moving towards fiber-based networking services. Increasing advancements in telecom industry is one of the major factors driving the growth of the fiber-optic filter market worldwide. Furthermore, the
Global Fiber Optic Cables (Fiber-optic Cable) Market By Key Players: Prysmian, H …
Qyresearchreports include new market research report "Global Fiber Optic Cables (Fiber-optic Cable) Sales Market Report 2018" to its huge collection of research reports. Fiber optic cable is a cable containing one or more optical fibers that are used to carry light. The optical fiber elements are typically individually coated with plastic layers and contained in a protective tube suitable for the environment where the cable will be deployed. In the last Five